Dr. Georgios Ioannidis is the Deputy Director of the Oncology Department of Nicosia General Hospital (NGH) in Nicosia. Dr Ioannidis is a graduate of the Medical School of the National & Kapodistrian University of Athens, Greece. He completed his specialist training in Medical Oncology at Saint Savas Anticancer Hospital in Athens, Greece in 2006. From 2006 to 2007, he worked as a Clinical Research Fellow in Medical Oncology at the University Hospital Southampton NHS Foundation Trust and the Cancer Research UK (CRUK) Centre in Southampton, UK. In 2007, he was appointed as a Consultant Medical Oncologist at NGH in Cyprus. Throughout his career, he has been awarded with several fellowships, including the European School of Oncology (ESO) Clinical Fellowship (2006) and the Hellenic Society of Medical Oncology Clinical and Research Fellowships (2009 and 2010). His research was conducted at the Laboratory of Translational Oncology of the University of Crete Medical School in Greece and was focused on the identification of molecular biomarkers predicting sensitivity to gemcitabine-based chemotherapy in patients with advanced-stage non-small cell lung cancer. Dr Ioannidis has worked as a Special Scientist at the Nursing Department of Cyprus Technology University, and is an active member of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Group, the European Society for Medical Oncology (ESMO) and the Hellenic Society for Medical Oncology (HeSMO). He has first- and co-authored more than 50 peer-reviewed journal and conference publications.